April 10, 2023
On April 7, 2023, a federal judge in Texas granted in part a motion for a preliminary injunction in a lawsuit challenging the U.S. Food and Drug Administration's (FDA) approval of the abortion pill mifepristone. The court stayed the FDA's approval of mifepristone, reasoning that the FDA's actions likely violated the Comstock Act and the Administrative Procedure Act. Read more about the Texas case here.
Also on April 7, 2023, a federal judge in Washington issued a preliminary injunction requiring the FDA to make no changes to the availability of mifepristone in the seventeen states involved in that lawsuit, citing the importance of preserving the status quo pending resolution on the merits. The plaintiff-states had sued the FDA and the U.S. Department of Health and Human Services to enjoin certain restrictions recently imposed on mifepristone. Read more about the Washington case here.